Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net loss $ (17,934,306) $ (10,256,167)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,443,856 1,223,207
Loss on disposal of assets 60,471  
Share-based compensation 2,432,758 962,143
Shares issued to vendors in exchange for services 30,899  
Amortization of right-of-use asset 517,985 42,799
Amortization of debt discount   26,728
Non-cash interest   352,171
Marketing services performed in exchange for convertible note   75,000
Deferred taxes   (150,000)
Changes in operating assets and liabilities:    
Accounts receivable and unbilled receivable 16,215 (245,481)
Prepaid expense and other assets 376,821 (380,738)
Other receivables 34,665 47,202
Security deposit   2,592
Accounts payable (432,986) 1,566,439
Accounts payable- related party   (15,725)
Accrued expenses (436,385) 397,317
Accrued fiduciary obligations (1,642,220) 993,041
Operating lease liabilities (512,095) (74,096)
Due To related party (437) (240,001)
Other liabilities (294,458) 147,001
Net cash used in operating activities (15,339,217) (5,526,568)
Cash flows from investing activities:    
Cash and restricted cash acquired as part of acquisitions (See Note 5)   11,384,035
Capitalization of software development costs (809,856) (1,211,511)
Purchase of property and equipment (70,176) (66,617)
Net cash (used in) provided by investing activities (880,032) 10,105,907
Cash flows from financing activities:    
Proceeds from stock options exercises   49
Proceeds from convertible notes   550,000
Proceeds from short-term loan   2,000,000
Proceeds from issuance of warrants   53,333
Net cash provided by financing activities   2,603,382
Net (decrease) increase in cash, cash equivalents and restricted cash (16,219,249) 7,182,721
Cash, cash equivalents and restricted cash at beginning of period 25,933,643 1,817,932
Cash, cash equivalents and restricted cash at end of period 9,714,394 9,000,653
Reconciliation of cash, cash equivalents, and restricted cash reported in the condensed consolidated balance sheet    
Cash and cash equivalents 4,747,951 1,190,974
Restricted cash 4,966,443 7,809,679
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statement of cash flows $ 9,714,394 $ 9,000,653